Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hammond

Showing results (651-660 of 711) with videos related to

Pageof 72
Sort By:
Arxiv|May 2, 2025
One pathogen does not an epidemic make: A review of interacting contagions, diseases, beliefs, and storiesLaurent Hébert-Dufresne, Yong-Yeol Ahn, Antoine Allard, et al.
The Journal of General Virology|October 18, 2024
A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsidsJohn D Clarke, Helen M E Duyvesteyn, Eva Perez-Martin, et al.
Journal for Immunotherapy of Cancer|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapyMohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignanciesM Hidalgo, M A Villalona-Calero, S G Eckhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcomaA M Davis, B O'Sullivan, R S Bell, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Cancer Research|December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cellsJérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Molecular Cancer Therapeutics|September 28, 2016
Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1Lawrence J Thomas, Laura Vitale, Thomas O'Neill, et al.
Plos Pathogens|May 18, 2018
Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pigKatie Tungatt, Garry Dolton, Sophie B Morgan, et al.
Nature Communications|January 24, 2024
Tumour-retained activated CCR7<sup>+</sup> dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activityColin Y C Lee, Bethany C Kennedy, Nathan Richoz, et al.
Pageof 72

Showing results (651-660 of 711) with videos related to

Sort By:
Pageof 72
Arxiv|May 2, 2025
One pathogen does not an epidemic make: A review of interacting contagions, diseases, beliefs, and storiesLaurent Hébert-Dufresne, Yong-Yeol Ahn, Antoine Allard, et al.
The Journal of General Virology|October 18, 2024
A broadly reactive ultralong bovine antibody that can determine the integrity of foot-and-mouth disease virus capsidsJohn D Clarke, Helen M E Duyvesteyn, Eva Perez-Martin, et al.
Journal for Immunotherapy of Cancer|May 19, 2026
Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapyMohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of PN401 and fluorouracil in patients with advanced solid malignanciesM Hidalgo, M A Villalona-Calero, S G Eckhardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcomaA M Davis, B O'Sullivan, R S Bell, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Cancer Research|December 25, 2013
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cellsJérémy Goc, Claire Germain, Thi Kim Duy Vo-Bourgais, et al.
Molecular Cancer Therapeutics|September 28, 2016
Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1Lawrence J Thomas, Laura Vitale, Thomas O'Neill, et al.
Plos Pathogens|May 18, 2018
Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pigKatie Tungatt, Garry Dolton, Sophie B Morgan, et al.
Nature Communications|January 24, 2024
Tumour-retained activated CCR7<sup>+</sup> dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activityColin Y C Lee, Bethany C Kennedy, Nathan Richoz, et al.
Pageof 72